PharmAthene, Inc.  

(Public, NYSEMKT:PIP)   Watch this stock  
Find more results for NYSEAMEX:PIP
1.69
0.00 (0.00%)
Jul 31 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.61 - 1.70
52 week 1.25 - 2.59
Open 1.69
Vol / Avg. 75,236.00/104,131.00
Mkt cap 107.81M
P/E     -
Div/yield     -
EPS -0.11
Shares 63.79M
Beta 2.27
Inst. own 41%
Aug 5, 2015
Q2 2015 PharmAthene Inc Earnings Release (Estimated) Add to calendar
May 7, 2015
Q1 2015 PharmAthene Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 20.70% -97.70%
Operating margin 16.43% -100.01%
EBITD margin - -98.54%
Return on average assets 24.74% -50.90%
Return on average equity 30.65% -77.75%
Employees 35 -
CDP Score - -

Address

1 Park Pl Ste 450
ANNAPOLIS, MD 21401-3481
United States - Map
+1-410-2692600 (Phone)
+1-410-2692601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Pharmathene, Inc. (Pharmathene) is a biodefense company. The Company is engaged in the development of medical counter measures against biological and chemical threats. The Company has several biodefense candidates in its portfolio: Anthrax vaccines, including SparVax, which is a second generation liquid recombinant protective antigen (rPA) anthrax vaccine, and a lyophilized anthrax vaccine containing rPA; rBChE (recombinant butyrylcholinesterase) bioscavenger, which is a medical counter measure for nerve agent poisoning by organophosphorous (OP) compounds, including nerve gases and pesticides, and Valortim, which is a fully human monoclonal antibody for the prevention and treatment of anthrax infection. The Company develops Valortim in collaboration with Bristol-Myers Squibb (BMS).

Officers and directors

Mitchel B. Sayare Ph.D. Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
John M. Gill President, Chief Executive Officer, Director
Age: 63
Bio & Compensation  - Reuters
Philip MacNeill Chief Financial Officer, Vice President, Treasurer, Secretary
Age: 62
Bio & Compensation  - Reuters
Jeffrey M. Jones Ph.D. Chief Operating Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
Eric I. Richman Director
Age: 54
Bio & Compensation  - Reuters
Jeffrey W. Runge M.D. Independent Director
Age: 59
Bio & Compensation  - Reuters
Derace L. Schaffer M.D. Independent Director
Age: 67
Bio & Compensation  - Reuters
Steven St. Peter M.D. Independent Director
Age: 48
Bio & Compensation  - Reuters